My mom was just diagnosed yesterday with IgG Lambda Multiple Myeloma with high-risk cytogenetics (del17p – 7%, gain 1q – 6%) from a oncologist/hematologist. We want to start induction treatment ASAP, but the soonest myeloma specialist appointment is late November. The oncologist (not a specialist) has recommended quadruplet Dara-VRd as induction therapy. My questions for the group: - How critical is it to see a myeloma specialist before starting induction therapy? - Has anyone compared Dara-VRd vs Dara-KRd, especially for high-risk patients? - Are there any other induction therapy options we should consider before moving forward? I really would appreciate any help as I am freshly new to navigating all of this. Thank you all so much!